Concepedia

Wendy A. Cyr

WA

Statistics

Publications

4

Citations

221

H-Index

4

Active since

2013

Affiliations

Dicerna Pharmaceuticals (United States)(Current)

Wendy A. Cyr is an author at Dicerna Pharmaceuticals (United States) specializing in nanotherapeutics, tumor biology, and cancer research.

Top concepts

Publications per year

2013–2017

4

Publications

4

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie W. Pursell et al. · Molecular Therapy · 2016 · 82 citations · Full text

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

Shanthi Ganesh, Martin L. Koser, Wendy A. Cyr et al. · Molecular Cancer Therapeutics · 2016 · 61 citations · Full text

, , +21

Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo

Henryk Dudek, Darren H. Wong, Rokhand Arvan et al. · Molecular Therapy · 2013 · 57 citations · Full text

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models

Shanthi Ganesh, Xue Shui, Kevin P. Craig et al. · Molecular Cancer Therapeutics · 2017 · 21 citations · Full text

1–4 of 4